Get In Touch

vaccines

Sanofi, Merck Vaccine To Bolster Vaccination Rates Across US

The US Food and Drug Administration (FDA) recently approved pharma giants Sanofi and Merck’s Vaxelis, a new pediatric vaccine against six diseases. The vaccine will help to bolster vaccination rates across the US by reducing the shot burden on infants and children, according to GlobalData, a leading data and analytics company. Vaxelis, which is indicated …

Sanofi, Merck Vaccine To Bolster Vaccination Rates Across US Read More »

Zika Virus Vaccines Market Size and Key Growth Drivers

It is predicted that Zika virus vaccines shot will available to the public by 2018. Zika virus is an emerging viral disease that is transmitted through the bite of an infected mosquito, primarily Aedes aegypti, the same vector that transmits chikungunya, dengue and yellow fever. Zika has a similar epidemiology, clinical presentation and transmission cycle …

Zika Virus Vaccines Market Size and Key Growth Drivers Read More »

Influenza Vaccine Market in Top 5 European Countries Insights and Major Trends Encouraging Growth until the End of 2022

Influenza Vaccine Market is expected to reach more than US$ 1 Billion across the 5 major markets (5MM) of the France, Germany, Italy, Spain and United Kingdom by the year end of 2022. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated …

Influenza Vaccine Market in Top 5 European Countries Insights and Major Trends Encouraging Growth until the End of 2022 Read More »

United States Influenza Vaccine 2016 Market Analysis focusing on Companies Analysis- Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZenecca, Protein Sciences Corporation, Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, VaxInnate

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine. The research report presents …

United States Influenza Vaccine 2016 Market Analysis focusing on Companies Analysis- Sanofi Pasteur, GlaxoSmithKline(GSK), Seqirus, AstraZenecca, Protein Sciences Corporation, Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, VaxInnate Read More »

Seasonal Influenza Vaccine Market Research Report- Opportunities & Challenges in Near Future by with Different Vaccines, Forecast- 2022

Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven major markets (7MM) of the United States, France, Germany, Italy, Spain, United Kingdom and Japan by the year end of 2022. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory …

Seasonal Influenza Vaccine Market Research Report- Opportunities & Challenges in Near Future by with Different Vaccines, Forecast- 2022 Read More »